Research Topics
| S YerlySummaryAffiliation: University Hospital Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infectionJorg Schupbach
Swiss National Center for Retroviruses, Institute of Medical Virology, University of Zurich, Switzerland
BMC Infect Dis 12:88. 2012....
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approachDimitrios Paraskevis
Katholieke Universiteit Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, B 3000 Leuven, Belgium
Retrovirology 6:49. 2009..However the spatial diffusion of the epidemic from the perspective of the virus has not previously been traced...
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals--the Swiss HIV Cohort StudyJan Fehr
Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Petersgraben 4, CH 4031 Basel, Switzerland
J Transl Med 9:14. 2011..The aim was to investigate whether the addition of rPRT to genotypic resistance testing (GRT) compared to GRT alone is beneficial for obtaining a virological response in heavily pre-treated HIV-infected patients...
Unusual primary HIV infection with colonic ulcer complicated by hemorrhagic shock: a case reportStephane Emonet
Department of Internal Medicine, University Hospitals Geneva, Rue Gabrielle Perret Gentil 4, Geneva, 1211, Switzerland
J Med Case Reports 4:279. 2010..However, although invasion of intestinal lymphoid tissue is a prominent feature of human and simian lentivirus infections, colonic ulceration has not been reported in acute HIV infection...
High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of diseaseJorg Schupbach
University of Zurich, Institute of Medical Virology, Swiss National Center for Retroviruses, Zurich, Switzerland
BMC Infect Dis 11:254. 2011..Here, we sought to further investigate the diagnostic specificity of various Inno-Lia algorithms and to identify factors affecting it...
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology surveySabine Yerly
Laboratory of Virology, University of Geneva Hospitals, Geneva, Switzerland
AIDS 21:2223-9. 2007..Representative prevalence data of transmitted drug-resistant HIV-1 are essential to establish accurate guidelines addressing resistance testing and first-line treatments...
Cytomegalovirus quantification in plasma by an automated real-time PCR assaySabine Yerly
Laboratory of Virology, University of Geneva Hospitals, 24 Rue Micheli du Crest, 1211 Geneva 14, Switzerland
J Clin Virol 38:298-303. 2007..Sensitive quantitation of cytomegalovirus (CMV) DNA in blood is helpful for the diagnosis of CMV infection or reactivation and the monitoring of transplanted patients...
[Detection and quantification of nucleic acids in infections diseases: utility and limitations]Sabine Yerly
Laboratoire central de virologie Service des maladies infectieuses Département de médecine interne Hôpitaux universitaires de Genève
Rev Med Suisse 1:887-90, 893-4. 2005..With the development of antiviral treatments quantitative PCR tests are now essential for the evaluation of treatment efficacy. A discussion with the laboratory is important for the correct interpretation of PCR results...
[Early diagnosis of primary HIV infections: using a combined screening test (p24 antigen and anti-HIV antibodies)]S Yerly
Laboratoire de Virologie, Hôptal Universitaire de Genève
Schweiz Med Wochenschr 129:319-22. 1999..The new screening assay was positive before a third-generation anti-HIV screening assay gave positive results in 14/34 patients (41%). Using the DUO assay, the mean reduction of the window period was 4 days...
Diagnosing acute HIV infectionSabine Yerly
Laboratory of Virology, Division of Laboratory Medicine, Department of Genetic and Laboratory Medicine, Switzerland
Expert Rev Anti Infect Ther 10:31-41. 2012..We review the clinical presentation of the acute retroviral syndrome, the laboratory markers and their detection methods, and propose an algorithm for the laboratory diagnosis of AHI...
The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infectionSabine Yerly
University of Geneva Medical School, Geneva s University Hospitals, Switzerland
AIDS 23:1415-23. 2009..To monitor HIV-1 transmitted drug resistance (TDR) in a well defined urban area with large access to antiretroviral therapy and to assess the potential source of infection of newly diagnosed HIV individuals...
Transforming laboratory test results to improve clinical outcome predictions in HIV patients. Swiss HIV Cohort StudyT V Perneger
Institute of Social and Preventive Medicine, University of Geneva Medical School, Switzerland
J Acquir Immune Defic Syndr Hum Retrovirol 17:442-9. 1998..1 transformation). Natural units of laboratory variables are not optimal for the prediction of clinical events in HIV-infected patients. Which transformation is best depends on the predictor under consideration...
Acute HIV infection: impact on the spread of HIV and transmission of drug resistanceS Yerly
University Hospital of Geneva, 1211 Geneva 14, Switzerland
AIDS 15:2287-92. 2001....
Time-dependence of survival predictions based on markers of HIV disease. Swiss HIV Cohort StudyT V Perneger
Institute of Social and Preventive Medicine, University of Geneva Medical School, Switzerland
J Investig Med 48:207-12. 2000..To determine whether the ability of baseline clinical stage, viremia, and CD4 cell counts to predict mortality in HIV-1-infected patients changes with duration of follow-up...
Nosocomial outbreak of multiple bloodborne viral infectionsS Yerly
Laboratory of Virology, Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland
J Infect Dis 184:369-72. 2001..HIV and HCV genotypic analyses identified a HIV monophyletic group, whereas 4 clusters of HCV sequences were identified. To our knowledge, this is the largest documented outbreak of nosocomial HIV transmission...
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsBilal Mohty
University Hospitals of Geneva, Centre for Vaccinology and Neonatal Immunology, Department of Pathology Immunology and Pediatrics, Medical Faculty, Geneva, Switzerland
Haematologica 96:896-904. 2011..The goal of this study was to assess the efficacy of the AS03-adjuvanted influenza H1N1/A/09 vaccine in allogeneic hematopoietic stem cell transplant recipients...
Infrequent transmission of HIV-1 drug-resistant variantsSabine Yerly
Laboratory of Virology and AIDS Center, Geneva University Hospital, Geneva, Switzerland
Antivir Ther 9:375-84. 2004..These data suggest that drug-resistant variants and in particular multidrug-resistant variants have a substantially reduced transmission capacity...
Clinical relevance of cytomegalovirus viraemia(*,†)E Boffi El Amari
HIV Unit, Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland
HIV Med 12:394-402. 2011..We investigated the prognostic value of a positive CMV DNA test for the development of CMV end-organ disease, other AIDS-defining events and mortality...
Zidovudine plus didanosine in primary HIV-1 infectionL Perrin
Laboratory of Virology, Geneva University Hospital, Switzerland
Antivir Ther 2:5-11. 1997..These data suggest a higher efficacy of combined therapy compared with zidovudine monotherapy in PHI patients and indicate that control of viraemia for at least 1 year is achievable in PHI patients...
High prevalence of non-B HIV-1 subtypes in seamen and their sexual partners in CroatiaMartha Kathleen Ramirez-Piedad
Laboratory of Virology, Divisions of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
J Med Virol 81:573-7. 2009..Non-B subtypes were found only in individuals with a heterosexual risk, mainly in seamen and their partners...
Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcomaFlorian Bihl
Department of Gastroenterology and Hepatology, University Hospital Geneva, Geneva, Switzerland
AIDS 23:1918-22. 2009..These data point toward a potential role of KSHV-specific immunity in the control of AIDS-associated Kaposi's sarcoma...
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemiaTristan Ferry
Geneva University Hospital, Geneva, Switzerland
Clin Infect Dis 50:115-8. 2010..Sixteen patients had circulating DNA, with no apparent clinical impact. Erythrovirus-associated anemia is an extremely rare event in HIV-infected patients...
Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavirS Yerly
Laboratory of Virology, University Hospital, Geneva, Switzerland
Antivir Ther 6:185-9. 2001..In nelfinavir subjects, 30N was the only primary mutation whereas isolated or combined 82A/T and 461/L mutations were detected in indinavir subjects...
Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapyL Perrin
AIDS Centre, Department of Otho Rhino Laryngology, Geneva University Hospital, Switzerland
J Infect Dis 177:1497-501. 1998..Six subjects had both detectable plasma viremia and evidence of HIV-1 RNA in lymphoid tissue. The results indicate that absence of detectable HIV RNA in lymphoid tissue is associated with viremia levels of HIV-1 RNA <20 copies/mL...
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patientsS Yerly
Central Laboratory of Virology, Geneva University Hospital, Switzerland
Antivir Ther 1:167-71. 1996..03). These data suggest that there was a better initial CD4 response to didanosine therapy in patients with HIV without the mutation at codon 215, but that this response did not translate into increased survival...
Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patientsSamir Vora
Laboratory of Virology, Geneva University Hospital, Switzerland
AIDS 20:35-40. 2006..CONCLUSIONS: The occurrence of three of the eight mutations in the ATV/RTV genotypic resistance score predicted a clinically identifiable reduced response in patients...
Travel and the spread of HIV-1 genetic variantsLuc Perrin
Laboratory of Virology, Division of Infectious Diseases, University of Geneva, Switzerland
Lancet Infect Dis 3:22-7. 2003..The spreading of HIV-1 variants has implications for diagnostic, treatment, and vaccine development...
Drug resistance mutations during structured treatment interruptionsSabine Yerly
Laboratory of Virology, Geneva University Hospital, Switzerland
Antivir Ther 8:411-5. 2003..55-fold higher in patients with the M184V/I mutation than in patients without detectable mutation (P=0.007). CONCLUSIONS: The M184V/I mutation is frequently selected during repeated treatment interruptions...
Chronic rhinoviral infection in lung transplant recipientsLaurent Kaiser
Central Laboratory of Virology, Division of Infectious Diseases, Department of Internal Medicine, University Hospitals of Geneva, Switzerland
Am J Respir Crit Care Med 174:1392-9. 2006..Lung transplant recipients are particularly at risk of complications from rhinovirus, the most frequent respiratory virus circulating in the community...
Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre studyPhilippe Brossard
Department of Gynaecology and Obstetrics, University of Geneva Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland
AIDS 22:2013-7. 2008....
A prospective trial of structured treatment interruptions in human immunodeficiency virus infectionCatherine Fagard
Division of Infectious Diseases, Geneva Unmiversity Hospital, 1211 Geneva 14, Switzerland
Arch Intern Med 163:1220-6. 2003..Treatment interruptions did not provoke clinical complications, and there was little drug resistance. Comparative trials will have to show what benefit, if any, is associated with intermittent, as opposed to continuous treatment...
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyCem Gabay
University Hospitals of Geneva and University of Geneva, Geneva, Switzerland
Arthritis Rheum 63:1486-96. 2011..To identify the determinants of antibody responses to adjuvanted split influenza A (H1N1) vaccines in patients with inflammatory rheumatic diseases...
Increased incidence of sexually transmitted infections in Geneva, SwitzerlandShahnaz Abraham
Department of Dermatology and Venereology, University Hospital of Geneva, Geneva, Switzerland
Dermatology 212:41-6. 2006..CONCLUSION: The situation in Geneva is similar to that observed elsewhere in Western Europe and indicates the need of public health interventions...
Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impactJorge Garbino
Department of Medicine, Division of Infectious Diseases, Central Laboratory of Virology, University Hospitals of Geneva, 24 rue Micheli-du-Crest, 1211 Geneva 14, Switzerland
Am J Respir Crit Care Med 170:1197-203. 2004..These viruses were associated with high morbidity, particularly in lung transplant recipients...
ALK-positive anaplastic large-cell lymphoma: strong T and B anti-tumour responses may cause hypocellular aspects of lymph nodes mimicking inflammatory lesionsB Borisch
Department of Pathology, University Hospital of Geneva, Geneva, Switzerland
Eur J Haematol 71:243-9. 2003..Hypocellular and oedematous lymph nodes occurring in a child with evocative symptoms should be tested for the presence of ALK...
A patient with HIV-1 superinfectionStephanie Jost
Division of Infectious Diseases, University of Geneva, Geneva
N Engl J Med 347:731-6. 2002
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infectionMilos Opravil
Division of Infectious Diseases, University Hospital, CH 8091 Zurich, Switzerland
J Infect Dis 185:1251-60. 2002....
HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtideDiane Descamps
AP HP, Groupe Hospitalier Bichat Claude Bernard, Laboratoire de Virologie, Paris F 75018, France
J Antimicrob Chemother 62:451-5. 2008..We studied gp41 mutations associated with failing enfuvirtide salvage therapy...
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovirViktor von Wyl
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
Clin Infect Dis 46:1299-309. 2008..We aimed to identify predictors for the emergence of K65R, using clinical data and genotypic resistance tests from the Swiss HIV Cohort Study...
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical managementAnnemarie M J Wensing
Eijkman Winkler Institute, Department of Virology, University Medical Center Utrecht, The Netherlands
J Infect Dis 192:958-66. 2005..These data argue for testing all drug-naive patients and are of relevance when guidelines for management of postexposure prophylaxis and first-line therapy are updated...
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell lossJorg Schupbach
Swiss National Center for Retroviruses, University of Zurich, Zurich, Switzerland
J Acquir Immune Defic Syndr 40:250-6. 2005..Persisting p24 despite successful HAART may reflect virus replication in reservoirs not represented by plasma viral load and has implications for the concept of therapeutic vaccination...
HIV-1 co/super-infection in intravenous drug usersSabine Yerly
AIDS 18:1413-21. 2004..In chronically infected IVDUs super-infection may be transient and may occur in patients controlling efficiently HIV infection by the initial strain...
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypesDavid A van de Vijver
Eijkman Winkler Institute, Department of Virology, University Medical Center Utrecht, G04-614, 3584 CX Utrecht, The Netherlands
J Acquir Immune Defic Syndr 41:352-60. 2006..Because of differences in minor protease substitutions, protease inhibitor resistance could be enhanced in particular subtypes once the relevant major substitutions are selected...
Prevalence of HIV-1 drug resistance in treated patients: a French nationwide studyDominique Costagliola
INSERM, Unité Mixte de Recherche UMR S 720, Universite Pierre et Marie Curie Paris 6, Paris, France
J Acquir Immune Defic Syndr 46:12-8. 2007..Surveillance of HIV-1 drug resistance in antiretroviral-treated patients is important from the public health perspective of the spread of resistance and to evaluate the proportion of patients for whom new drugs are needed...
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen typesViktor von Wyl
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Ramistr 100, CH 8091 Zurich, Switzerland
Arch Intern Med 167:1782-90. 2007..Differences between these regimen types in the extent of the emergence of drug resistance on virological failure and the implications for further treatment options have rarely been assessed...
Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmationJorg Schupbach
University of Zurich, Swiss National Center for Retroviruses, Zurich, Switzerland
PLoS Med 4:e343. 2007..We have investigated whether this "recency" information can also be gained from an HIV confirmatory assay...
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort StudyMarcel Wolbers
Basel Institute for Clinical Epidemiology, University Hospital Basel, Switzerland
AIDS 21:2201-7. 2007....
Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptionsSabine Yerly
AIDS 18:1951-3. 2004....
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialJintanat Ananworanich
HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
Lancet 368:459-65. 2006..Treatment-related adverse events were more frequent with continuous treatment, but low CD4 counts and minor manifestations of HIV infection were more frequent with scheduled treatment interruption...
The trap: professional exposure to human immunodeficiency virus antibody negative blood with high viral loadStefano Giulieri
Service of Infectious Diseases, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon 46, 1011, Lausanne, Switzerland
Arch Intern Med 167:2524-6. 2007
Amplicon sequencing and improved detection of human rhinovirus in respiratory samplesChristelle Deffernez
Central Laboratory of Virology, Division of Infectious Diseases, Department of Internal Medicine, University Hospitals of Geneva, 24 rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland
J Clin Microbiol 42:3212-8. 2004..By sequencing the 5' noncoding regions of rhinoviruses recovered from clinical specimens, we designed probes that could specifically detect rhinovirus...
